Davita Inc vs Peloton Interactive Inc — how do they compare? Davita Inc trades at $232 (market cap $14.92B), while Peloton Interactive Inc trades at $6.17 (market cap $2.67B). The key difference: Davita Inc is far larger — about 5.6× Peloton Interactive Inc's market cap, and Davita Inc is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals.
| DVA | PTON | |
|---|---|---|
Market Cap | $14.92B | $2.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $235.71 | $9.00 |
52-Week Low | $103.87 | $3.71 |
Enterprise Value | $27.47B | $3.27B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
Peloton (PTON) trades at $6.08, up 3.75% on the day, as technical indicators show a bullish trend with neutral oscillators. The company has achieved a significant turnaround in cash flow, with operating cash flow positive at $333 million in 2025, and is projected to return to net profitability in 2026. However, revenue continues to decline, and the stock carries a high P/E ratio of 101.25, reflecting investor optimism about future earnings despite current challenges. Recent news highlights inclusion in the S&P SmallCap 600 index and leadership changes.
The outlook for PTON hinges on sustaining profitability and reversing revenue declines. Opportunities include strong free cash flow generation and cost-cutting success, but risks involve persistent revenue shrinkage, high debt levels, and intense competition. Analyst consensus is cautiously optimistic with a $7.50 price target, suggesting potential upside if execution improves.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →